Advances in incretin-based therapeutics for obesity

Nat Rev Endocrinol. 2024 Feb;20(2):67-68. doi: 10.1038/s41574-023-00938-w.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Incretins* / therapeutic use
  • Obesity / drug therapy

Substances

  • Incretins